ArticleCancer drug resistance (Alhambra, Calif.)2026

LINC01607 promotes hepatocellular carcinoma progression and ferroptosis-associated therapy resistance with functional involvement of the p62-Keap1-Nrf2 pathway.

Yuxin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.